ETF DAILY NEWS

Analysts Set Quince Therapeutics, Inc. (NASDAQ:QNCX) PT at $8.00

Quince Therapeutics, Inc. (NASDAQ:QNCX – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven research firms that are presently covering the firm, MarketBeat Ratings reports. Five analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 1 year […]

May 10, 2025 - 06:34
 0
Analysts Set Quince Therapeutics, Inc. (NASDAQ:QNCX) PT at $8.00
Quince Therapeutics, Inc. (NASDAQ:QNCX – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven research firms that are presently covering the firm, MarketBeat Ratings reports. Five analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 1 year […]
Read More

Tags:

Previous Article

Brokerages Set Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Target Price at $3.33

Next Article

Helios Towers’ (HTWS) “Buy” Rating Reiterated at Berenberg Bank

Related Posts

Analysts Set Celestica Inc. (NYSE:CLS) PT at $103.25

Analysts Set Celestica Inc. (NYSE:CLS) PT at $103.25

Apr 25, 2025  0

Research Analysts Set Expectations for TSE:FN Q2 Earnings

Research Analysts Set Expectations for TSE:FN Q2 Earnings

May 3, 2025  0

Renaissance Technologies LLC Has $2.67 Million Stock Holdings in Gladstone Land Co. (NASDAQ:LAND)

Renaissance Technologies LLC Has $2.67 Million Stock Ho...

Apr 25, 2025  0